Vishal G. Kamat, Ph.D.
Affiliations: | 2010 | Drexel University, Philadelphia, PA, United States |
Area:
Biomedical EngineeringGoogle:
"Vishal Kamat"Parents
Sign in to add mentor| Elisabeth S. Papazoglou | grad student | 2010 | Drexel | |
| (Combined use of multiple monoclonal antibodies targeting epidermal growth factor receptor for improved cancer therapeutics.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shapiro MB, Boucher J, Brousseau A, et al. (2023) Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform. Antibody Therapeutics. 6: 211-223 |
| Aykul S, Huang L, Wang L, et al. (2022) ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. The Journal of Clinical Investigation |
| Kamat V, Boutot C, Rafique A, et al. (2021) High affinity human Fc specific monoclonal antibodies for capture kinetic analyses of antibody-antigen interactions. Analytical Biochemistry. 114455 |
| Gevaert P, De Craemer J, De Ruyck N, et al. (2021) Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study. The Journal of Allergy and Clinical Immunology |
| Atanasio A, Franklin MC, Kamat V, et al. (2021) Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response. The Journal of Allergy and Clinical Immunology |
| Waite JC, Wang B, Haber L, et al. (2020) Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Science Translational Medicine. 12 |
| Latuszek A, Liu Y, Olsen O, et al. (2020) Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5. Plos One. 15: e0231892 |
| Kamat V, Rafique A, Huang T, et al. (2020) The impact of different human IgG capture molecules on the kinetics analysis of antibody-antigen interaction. Analytical Biochemistry. 593: 113580 |
| Atanasio A, Franklin M, Ben L, et al. (2020) Targeting birch allergy with monoclonal IgG antibodies that bind allergen and prevent IgE effector cell activation Journal of Allergy and Clinical Immunology. 145: AB62 |
| Orengo JM, Radin AR, Kamat V, et al. (2018) Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nature Communications. 9: 1421 |